The role of galectin-1 in trophoblast differentiation and signal transduction

Journal of Reproductive Immunology

Volumn 90, Issue 1, 2011, Pages 35-40

  Fischer, Isabelle ^a   Jeschke, Udo ^a   Friese, Klaus ^a   Daher, Silvia ^b   Betz, Alexander G ^c  

^a UNIVERSITY OF MUNICH   (Germany)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

BeWo; Galectin 1; Signal transduction; Syncytium formation

Indexed keywords

GALECTIN 1; PROTEIN TYROSINE KINASE;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; EMBRYO DEVELOPMENT; HORMONE SYNTHESIS; HUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SYNCYTIUM; TROPHOBLAST;

CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; FEMALE; GALACTOSIDES; GALECTIN 1; GIANT CELLS; HUMANS; JANUS KINASE 2; PREGNANCY; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; TROPHOBLASTS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 79959932573     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2011.04.004     Document Type: Article

References (67)

1. Adams L., Scott G.K., Weinberg C.S. Biphasic modulation of cell growth by recombinant human galectin-1. Biochim. Biophys. Acta 1996, 1312:137-144.
2. Aluvihare V.R., Kallikourdis M., Betz A.G. Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol. 2004, 5:266-271.
3. Avril T., Jarousseau A.C., Watier H., Boucraut J., Le Bouteiller P., Bardos P., et al. Trophoblast cell line resistance to nk lysis mainly involves an HLA class I-independent mechanism. J. Immunol. 1999, 162:5902-5909.
4. Baloh R.H., Tansey M.G., Golden J.P., Creedon D.J., Heuckeroth R.O., Keck C.L., et al. TrnR2, a novel receptor that mediates neurturin and GDNF signaling through. Ret. Neuron. 1997, 18:793-802.
5. Blois S.M., Ilarregui J.M., Tometten M., Garcia M., Orsal A.S., Cordo-Russo R., et al. A pivotal role for galectin-1 in fetomaternal tolerance. Nat. Med. 2007, 13:1450-1457.
6. Buj-Bello A., Adu J., Pinon L.G., Horton A., Thompson J., Rosenthal A., et al. Neurturin responsiveness requires a GPI-linked receptor and the Ret receptor tyrosine kinase. Nature 1997, 387:721-724.
7. Chiariello M., Visconti R., Carlomagno F., Melillo R.M., Bucci C., De Franciscis V., et al. Signalling of the Ret receptor tyrosine kinase through the c-jun NH2-terminal protein kinases (JNKS): evidence for a divergence of the ERKs and JNKs pathways induced by Ret. Oncogene 1998, 16:2435-2445.
8. Clark G.F., Dell A., Morris H.R., Patankar M.S., Easton R.L. The species recognition system: a new corollary for the human fetoembryonic defense system hypothesis. Cells Tissues Organs 2001, 168:113-121.
9. Cooper D.N., Barondes S.H. Evidence for export of a muscle lectin from cytosol to extracellular matrix and for a novel secretory mechanism. J. Cell. Biol. 1990, 110:1681-1691.
10. Coutifaris C., Kao L.C., Sehdev H.M., Chin U., Babalola G.O., Blaschuk O.W., et al. E-cadherin expression during the differentiation of human trophoblasts. Development 1991, 113:767-777.
11. Daoud G., Amyot M., Rassart E., Masse A., Simoneau L., Lafond J. ERK1/2 and p38 regulate trophoblasts differentiation in human term placenta. J. Physiol. 2005, 566:409-423.
12. Fischer I., Schulze S., Kuhn C., Friese K., Walzel H., Markert U.R., et al. Inhibiton of RET and JAK2 signals and upregulation of VEGFR3 phosphorylation in vitro by galectin-1 in trophoblast tumor cells BeWo. Placenta 2009, 30:1078-1082.
13. Fischer I., Redel S., Hofmann S., Kuhn C., Friese K., Walzel H., et al. Stimulation of syncytium formation in vitro in human trophoblast cells by galectin-1. Placenta 2010, 31:825-832.
14. Fitzgerald J.S., Busch S., Wengenmayer T., Foerster K., De La Motte T., Poehlmann T.G., et al. Signal transduction in trophoblast invasion. Chem. Immunol. Allergy 2005, 88:181-199.
15. Fitzgerald J.S., Tsareva S.A., Poehlmann T.G., Berod L., Meissner A., Corvinus F.M., et al. Leukemia inhibitory factor triggers activation of signal transducer and activator of transcription 3, proliferation, invasiveness, and altered protease expression in choriocarcinoma cells. Int. J. Biochem. Cell Biol. 2005, 37:2284-2296.
16. Fitzgerald J.S., Poehlmann T.G., Schleussner E., Markert U.R. Trophoblast invasion: the role of intracellular cytokine signalling via signal transducer and activator of transcription 3 (stat3). Hum. Reprod. Update 2008, 14:335-344.
17. Frendo J.L., Cronier L., Bertin G., Guibourdenche J., Vidaud M., Evain-Brion D., et al. Involvement of connexin 43 in human trophoblast cell fusion and differentiation. J. Cell Sci. 2003, 116:3413-3421.
18. Fukuda T., Kiuchi K., Takahashi M. Novel mechanism of regulation of Rac activity and lamellipodia formation by RET tyrosine kinase. J. Biol. Chem. 2002, 277:19114-19121.
19. Georgiadis V., Stewart H.J., Pollard H.J., Tavsanoglu Y., Prasad R., Horwood J., et al. Lack of galectin-1 results in defects in myoblast fusion and muscle regeneration. Dev. Dyn. 2007, 236:1014-1024.
20. Getsios S., Maccalman C.D. Cadherin-11 modulates the terminal differentiation and fusion of human trophoblastic cells in vitro. Dev. Biol. 2003, 257:41-54.
21. Getsios S., Chen G.T., Maccalman C.D. Regulation of beta-catenin mRNA and protein levels in human villous cytotrophoblasts undergoing aggregation and fusion in vitro: correlation with E-cadherin expression. J. Reprod. Fertil. 2000, 119:59-68.
22. Harrison F.L., Wilson T.J. The 14kda beta-galactoside binding lectin in myoblast and myotube cultures: localization by confocal microscopy. J. Cell Sci. 1992, 101(Pt 3):635-646.
23. Hirabayashi J., Kasai K. Human placenta beta-galactoside-binding lectin purification and some properties. Biochem. Biophys. Res. Commun. 1984, 122:938-944.
24. Hughes R.C. Galectins as modulators of cell adhesion. Biochimie 2001, 83:667-676.
25. Hunter T. The Croonian lecture 1997 The phosphorylation of proteins on tyrosine: its role in cell growth and disease. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1998, 353:583-605.
26. Jeschke U., Richter D.U., Hammer A., Briese V., Friese K., Karsten U. Expression of the Thomsen-Friedenreich antigen and of its putative carrier protein mucin 1 in the human placenta and in trophoblast cells in vitro. Histochem. Cell Biol. 2002, 117:219-226.
27. Jeschke U., Reimer T., Bergemann C., Wiest I., Schulze S., Friese K., et al. Binding of galectin-1 (gal-1) on trophoblast cells and inhibition of hormone production of trophoblast tumor cells in vitro by gal-1. Histochem. Cell Biol. 2004, 121:501-508.
28. Jeschke U., Karsten U., Wiest I., Schulze S., Kuhn C., Friese K., et al. Binding of galectin-1 (gal-1) to the Thomsen-Friedenreich (TF) antigen on trophoblast cells and inhibition of proliferation of trophoblast tumor cells in vitro by gal-1 or an anti-TF antibody. Histochem. Cell Biol. 2006, 126:437-444.
29. Jeschke U., Mayr D., Schiessl B., Mylonas I., Schulze S., Kuhn C., et al. Expression of galectin-1, -3 (gal-1, gal-3) and the Thomsen-Friedenreich (TF) antigen in normal, IUGR, preeclamptic and HELLP placentas. Placenta 2007, 28:1165-1173.
30. Jhiang S.M. The ret proto-oncogene in human cancers. Oncogene 2000, 19:5590-5597.
31. Jing S., Wen D., Yu Y., Holst P.L., Luo Y., Fang M., et al. GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell 1996, 85:1113-1124.
32. Kita N., Mitsushita J., Ohira S., Takagi Y., Ashida T., Kanai M., et al. Expression and activation of MAP kinases ERK1/2, in the human villous trophoblasts. Placenta 2003, 24:164-172.
33. Kopcow H.D., Rosetti F., Leung Y., Allan D.S., Kutok J.L., Strominger J.L. T cell apoptosis at the maternal-fetal interface in early human pregnancy, involvement of galectin-1. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:18472-18477.
34. Kurenova E.V., Hunt D.L., He D., Fu A.D., Massoll N.A., Golubovskaya V.M., et al. Vascular endothelial growth factor receptor-3 promotes breast cancer cell proliferation, motility and survival in vitro and tumor formation in vivo. Cell Cycle 2009, 8:2266-2280.
35. Lin H., Mosmann T.R., Guilbert L., Tuntipopipat S., Wegmann T.G. Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J. Immunol. 1993, 151:4562-4573.
36. Malassine A., Handschuh K., Tsatsaris V., Gerbaud P., Cheynet V., Oriol G., et al. Expression of HERV-W Env glycoprotein (syncytin) in the extravillous trophoblast of first trimester human placenta. Placenta 2005, 26:556-562.
37. Pachnis V., Mankoo B., Costantini F. Expression of the c-ret proto-oncogene during mouse embryogenesis. Development 1993, 119:1005-1017.
38. Perillo N.L., Pace K.E., Seilhamer J.J., Baum L.G. Apoptosis of T cells mediated by galectin-1. Nature 1995, 378:736-739.
39. Plaza Menacho I., Koster R., Van Der Sloot A.M., Quax W.J., Osinga J., Van Der Sluis T., et al. RET-familial medullary thyroid carcinoma mutants Y791F and S891A activate a Src/JAK/STAT3 pathway, independent of glial cell line-derived neurotrophic factor. Cancer Res. 2005, 65:1729-1737.
40. Proll J., Blaschitz A., Hutter H., Dohr G. First trimester human endovascular trophoblast cells express both HLA-C and HLA-G. Am. J. Reprod. Immunol. 1999, 42:30-36.
41. Rabinovich G.A. Galectins: an evolutionarily conserved family of animal lectins with multifunctional properties; a trip from the gene to clinical therapy. Cell Death Differ. 1999, 6:711-721.
42. Rabinovich G.A., Daly G., Dreja H., Tailor H., Riera C.M., Hirabayashi J., et al. Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via t cell apoptosis. J. Exp. Med. 1999, 190:385-398.
43. Rabinovich G.A., Sotomayor C.E., Riera C.M., Bianco I., Correa S.G. Evidence of a role for galectin-1 in acute inflammation. Eur. J. Immunol. 2000, 30:1331-1339.
44. Rabinovich G.A., Ramhorst R.E., Rubinstein N., Corigliano A., Daroqui M.C., Kier-Joffe E.B., et al. Induction of allogenic T-cell hyporesponsiveness by galectin-1-mediated apoptotic and non-apoptotic mechanisms. Cell Death Differ. 2002, 9:661-670.
45. Rabinovich G.A., Rubinstein N., Fainboim L. Unlocking the secrets of galectins: a challenge at the frontier of glyco-immunology. J. Leukoc. Biol. 2002, 71:741-752.
46. Rabinovich G.A., Rubinstein N., Toscano M.A. Role of galectins in inflammatory and immunomodulatory processes. Biochim. Biophys. Acta 2002, 1572:274-284.
47. Raz A., Lotan R. Endogenous galactoside-binding lectins: a new class of functional tumor cell surface molecules related to metastasis. Cancer Metastasis Rev. 1987, 6:433-452.
48. Richter D.U., Jeschke U., Makovitzky J., Goletz S., Karsten U., Briese V., et al. Expression of the Thomsen-Friedenreich (TF) antigen in the human placenta. Anticancer Res. 2000, 20:5129-5133.
49. Sasaki Y., Sakai M., Miyazaki S., Higuma S., Shiozaki A., Saito S. Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol. Hum. Reprod. 2004, 10:347-353.
50. Schiessl B., Innes B.A., Bulmer J.N., Otun H.A., Chadwick T.J., Robson S.C., et al. Localization of angiogenic growth factors and their receptors in the human placental bed throughout normal human pregnancy. Placenta 2009, 30:79-87.
51. Schuringa J.J., Wojtachnio K., Hagens W., Vellenga E., Buys C.H., Hofstra R., et al. MEN2A-RET-induced cellular transformation by activation of STAT3. Oncogene 2001, 20:5350-5358.
52. Shibuya M., Claesson-Welsh L. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp. Cell Res. 2006, 312:549-560.
53. Thijssen V.L., Postel R., Brandwijk R.J., Dings R.P., Nesmelova I., Satijn S., et al. Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:15975-15980.
54. Thijssen V.L., Barkan B., Shoji H., Aries I.M., Mathieu V., Deltour L., et al. Tumor cells secrete galectin-1 to enhance endothelial cell activity. Cancer Res. 2010, 70:6216-6224.
55. Toscano M.A., Commodaro A.G., Ilarregui J.M., Bianco G.A., Liberman A., Serra H.M., et al. Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2- and T regulatory-mediated anti-inflammatory responses. J. Immunol. 2006, 176:6323-6332.
56. Treanor J.J., Betts R.F., Smith G.E., Anderson E.L., Hackett C.S., Wilkinson B.E., et al. Evaluation of a recombinant hemagglutinin expressed in insect cells as an influenza vaccine in young and elderly adults. J. Infect. Dis. 1996, 173:1467-1470.
57. Treanor J.J., Goodman L., De Sauvage F., Stone D.M., Poulsen K.T., Beck C.D., et al. Characterization of a multicomponent receptor for GDNF. Nature 1996, 382:80-83.
58. Van Der Leij J., Van Den Berg A., Blokzijl T., Harms G., Van Goor H., Zwiers P., et al. Dimeric galectin-1 induces IL10 production in T-lymphocytes: an important tool in the regulation of the immune response. J. Pathol. 2004, 204:511-518.
59. Vicovac L., Jankovic M., Cuperlovic M. Galectin-1 and -3 in cells of the first trimester placental bed. Hum. Reprod. 1998, 13:730-735.
60. Walzel H., Neels P., Bremer H., Kohler H., Raab N., Barten M., et al. Immunohistochemical and glycohistochemical localization of the beta-galactoside-binding s-type lectin in human placenta. Acta Histochem. 1995, 97:33-42.
61. Walzel H., Schulz U., Neels P., Brock J. Galectin-1, a natural ligand for the receptor-type protein tyrosine phosphatase CD45. Immunol. Lett. 1999, 67:193-202.
62. Walzel H., Blach M., Hirabayashi J., Kasai K.I., Brock J. Involvement of CD2 and CD3 in galectin-1 induced signaling in human Jurkat T-cells. Glycobiology 2000, 10:131-140.
63. Walzel H., Blach M., Hirabayashi J., Arata Y., Kasai K., Brock J. Galectin-induced activation of the transcription factors NFAT and AP-1 in human Jurkat T-lymphocytes. Cell Signal. 2002, 14:861-868.
64. Wells V., Mallucci L. Identification of an autocrine negative growth factor: mouse beta-galactoside-binding protein is a cytostatic factor and cell growth regulator. Cell 1991, 64:91-97.
65. Wice B., Menton D., Geuze H., Schwartz A.L. Modulators of cyclic AMP metabolism induce syncytiotrophoblast formation in vitro. Exp. Cell Res. 1990, 186:306-316.
66. Wiest I., Seliger C., Walzel H., Friese K., Jeschke U. Induction of apoptosis in human breast cancer and trophoblast tumor cells by galectin-1. Anticancer Res. 2005, 25:1575-1580.
67. Zabaglo L., Ormerod M.G., Dowsett M. Measurement of proliferation marker ki67 in breast tumour FNAs using laser scanning cytometry in comparison to conventional immunocytochemistry. Cytometry B Clin. Cytom. 2003, 56:55-61.